−11.11 M SEK
0.00 SEK
About APTAHEM AB
Sector
CEO
Knut Mikael Ingolf Lindstam
Headquarters
Malmö
Website
Founded
2014
ISIN
SE0022447173
FIGI
BBG008GSTLB3
Aptahem AB is a biotechnology company, which engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded by Luiza Jedlina, Bert Junno, Tina Persson, Mikael Lindstam and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APTA is 1.420 SEK — it has increased by 26.64% in the past 24 hours. Watch APTAHEM AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange APTAHEM AB stocks are traded under the ticker APTA.
APTA stock has risen by 22.36% compared to the previous week, the month change is a 5.07% rise, over the last year APTAHEM AB has showed a −83.29% decrease.
We've gathered analysts' opinions on APTAHEM AB future price: according to them, APTA price has a max estimate of 12.22 SEK and a min estimate of 12.22 SEK. Watch APTA chart and read a more detailed APTAHEM AB stock forecast: see what analysts think of APTAHEM AB and suggest that you do with its stocks.
APTA reached its all-time high on Jan 12, 2016 with the price of 2,670.265 SEK, and its all-time low was 1.090 SEK and was reached on Dec 23, 2024. View more price dynamics on APTA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APTA stock is 6.38% volatile and has beta coefficient of 0.30. Track APTAHEM AB stock price on the chart and check out the list of the most volatile stocks — is APTAHEM AB there?
Yes, you can track APTAHEM AB financials in yearly and quarterly reports right on TradingView.
APTA net income for the last quarter is −1.18 M SEK, while the quarter before that showed −2.63 M SEK of net income which accounts for 55.16% change. Track more APTAHEM AB financial stats to get the full picture.
No, APTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 9.00 employees. See our rating of the largest employees — is APTAHEM AB on this list?
Like other stocks, APTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTAHEM AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APTAHEM AB technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APTAHEM AB stock shows the sell signal. See more of APTAHEM AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.